Search results for: 'biologics contracnt development and manufacturing'

25 Jul 2016  |  Europe  |  Market Research

Analysis of the Global Biologics API Market

Redefining the Future of Biologics through Target-specific Drugs and Novel Technologies

Infographics

×

This study provides an insight into the global biologics active pharmaceutical ingredients (API) market. According to the US FDA, “Biological products, or biologics, are medical products made from a variety of natural sources (human, animal, or microorganism). Biologics are intended to treat diseases & medical conditions and prevent or diagnose dis...

Microbiome research is on the rise following technological advancements and significant cost reductions in microbiome analysis. Research has unlocked the potential of microbiome in medical use cases, yielding tremendous insights on its nature, interactions, and impact within a host and in an external environment. Advanced studies on the role of mic...

This Frost Radar™ analyzes the competitive landscape of the antibody-drug conjugate (ADC) contract development and manufacturing organization (CDMO) market. Companies provide the foundational manufacturing and development services for what has become one of the most dynamic and valuable therapeutic modalities in oncology. The success of the ADC rev...

10 Sep 2024  |  Global  |  Technology Research

Technology Advances in Modular and Automated Platforms for Pharmaceutical Manufacturing

Increasing demand for small molecule drugs is driving the growth of modular and automated technologies in pharmaceutical manufacturing

Infographics

×

This study examines technology advances in modular and automated platforms for non-biologics manufacturing in the pharmaceutical sector. There is a growing demand for automated and modular technologies that ensure regulatory compliance, increase productivity, reduce waste, and meet emerging therapeutic requirements such as those of the personalized...

Immuno-oncology (I-O) therapies target tumors by harnessing the host s immune system. With the growing incidence and prevalence of various types of aggressive and refractory cancers, the next-generation I-O therapy pipeline has witnessed significant growth. Chimeric antigen receptor (CAR)-T cell therapy and tumor-targeted antibody therapies, includ...

This edition of the Life Science, Health & Wellness Technology Opportunity Engine (TOE) provides actionable insights across new developments in oncology, immunology, autoimmune disorders, and precision medicine, highlighting next-generation biologics, bispecific antibodies, kinase inhibitors, molecular glues, and antibody engineering platforms. The...

10 Aug 2022  |  Global  |  Market Research

Global Satellite Component Manufacturing Growth Opportunities

Distributed Governance, Digital Technologies, Cyber Resilience, & Standardized Commercial-off-the-Shelf Components to Stimulate the Growing NewSpace Economy

Infographics

×

An emerging commercial space industry, driven primarily by satellite miniaturization for low Earth orbit (LEO) operation, has disrupted space regimes. With 4,852 satellites in orbit and an expected capacity of 19,282 by 2030, the development of the downstream sector has been influenced by solid space technology advancements and broader global techn...

This Frost & Sullivan analysis examines the technological and industrial landscape of sustainable manufacturing for flexible electronics. It reviews the top 10 technologies and trends, assessing their relevance, maturity, and potential to enable environmentally responsible, high-efficiency production. It explores how these technologies can reduce m...

Environmental concerns are compelling governments and companies to switch to a green manufacturing model. Manufacturers across various sectors may have different motivations to adopt sustainable practices; for some, it could be complying with government regulations, while for others, it could be to build a green label and gain customer loyalty or i...